Aptagen, LLC
RNA
Human Influenza A virus H3N2
Cells
0.188 nM (reported value)
Binding Buffer (20 nM HEPES/KOH (pH 7?ú4), 105 mM NaCl) PIPES buffer (5 mM PIPES/NaOH, 145 mM NaCl (pH 7?ú5)) Acidic buffer (145 mM NaCl, 20 mM sodium citrate, 1 U RNase inhibitor µl-1 (pH 5?ú0))
N/A°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
Human Influenza A virus H3N2 (P30-10-16) (ID# 121)
5'rGprGprGprAprGprAprAprUprUprCprCprGprAprCprCprAprGprAprAprGprGprGprUprUprAprGprCprAprGprUprCprGprGprCprAprUprGprCprGprGprUprAprCprAprGprAprCprAprGprAprCprCprUprUprUprCprCprUprCprUprCprUprCprCprUprUprCprCprUprCprUprUprCprUp3'
74
23621.16 g/mole
710100 L/(mole·cm)
54.05%
1.41
33.26
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Gopinath, S., et al. "An RNA aptamer that distinguishes between closely related human influenza viruses and inhibits haemagglutinin-mediated membrane fusion." Journal of General Virology, 87(2005): 479-487.
Have your aptamer oligo synthesized ORDER NOW
We are always looking for ways to improve. Please tell us what you think.